Although the mechanism of anti-tumor activity of CBD in TNBC cells is yet to be fully elucidated, Elbaz et al. reported that CBD exerts its activity by inhibiting the EGF-induced activation of NF-κβ, migration, ERK, and AKT signaling pathways. The gene discussed is AKT1; the disease is neoplasm.